Type 2 diabetes with HbA1C >7.5% in the last 12 months Nutritional, Metabolic, Endocrine Diabetes
Conditions
Interventions
Intervention group: will receive telephone coaching sessions from existing practice nurses over an 18-month period. The telephone coaching session is a patient-centred program for disease self-managem
Sponsors
National Health and Medical Research Council (Australia)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 06/02/2009: 1. General practices will be included in the study if practices are computerised 2. >50% of Practice GPs agree to participate and to be randomised to intervention or control group 3. GPs are willing to search their medical records and pathology database with assistance from research team and be willing to recruit patients with T2D from their practices in accordance with privacy and ethical guidelines 4. Patients with T2D will be invited to participate if they are >18 years with haemoglobin HbA1c (HbA1c) >7.5% and receiving care from general practices in the northern or northwest region of Melbourne that employ a practice nurse. Previous inclusion criteria: 1. General practices will be included in the study if practices are computerised 2. >50% of Practice GPs agree to participate and to be randomised to intervention or control group 3. GPs are willing to search their medical records database with assistance from research team and be willing to recruit patients with T2D from their practices in accordance with privacy and ethical guidelines 4. Patients with T2D will be invited to participate if they are >18 years with haemoglobin HbA1c (HbA1c) >7.5% and receiving care from general practices in the northern or northwest region of Melbourne that employ a practice nurse.
Exclusion criteria
Exclusion criteria: 1. Patients will be excluded if they are not contactable by telephone 2. Patients having a complex debilitating coexisting medical condition e.g. mental illness, end-stage cancer 3. Patients who do not provide signed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change in HbA1c level from baseline to 12 and 18 months post-randomisation in the intervention group compared with the control group | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparative change from baseline to follow-up of: 1. Process of GP care measures 2. Diabetes therapy 3. Antihypertensive therapy 4. Statin therapy 5. Aspirin therapy 6. Total cholesterol, triglyceride, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels, urinary albumin, blood pressure, body mass index, quality of life, diabetes self-efficacy, depression, and cost-effectiveness Added as of 06/02/2009: Follow-up assessments will be carried out at 12 and 18 months post-baseline assessments | — |
Countries
Australia
Outcome results
None listed